Also, there were no modifications of YKL-40 in AD or in prodromal AD, while in the Craig-Schapiro study from 2010 [30] the cohort was larger than in Mattsson study, with the reported group differences “being small with large overlaps, making the findings difficult to reproduce”, as stated by [25]. Here, CHI3L1 is linked to Alzheimer disease.